Interpace Biosciences, Inc. Share Price
Stocks
IDXGD
US46062X4025
Healthcare Facilities & Services
OTC Markets Traded|
Market Closed -
OTC Markets
19:10:25 22/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 6.470 USD | +0.31% |
|
-0.46% | +5.19% |
| Market Cap | 35.84M 31.32M 29.44M 26.87M 50.42M 3.43B 50.43M 353M 136M 1.75B 135M 132M 5.64B | P/E 2024 |
6.84x | P/E 2025 | 1.39x |
|---|---|---|---|---|---|
| Enterprise Value | 34.52M 30.17M 28.36M 25.88M 48.56M 3.3B 48.57M 340M 131M 1.69B 130M 127M 5.43B | EV / Sales 2024 |
0.35x | EV / Sales 2025 | 0.11x |
| Free-Float |
8.77% | Yield 2024 * |
-
| Yield 2025 | - |
OTC MarketsUSD
| Markets | Quality | ||
|---|---|---|---|
OTC Markets
| IDXGD | Delayed | |
Börse Stuttgart
| PF4 | Delayed | |
Boerse Muenchen
| PF4 | Real-time |
| 1 day | +0.31% | ||
| 1 week | -0.46% | ||
| Current month | -14.53% | ||
| 1 month | -15.02% | ||
| 3 months | -20.61% | ||
| 6 months | -23.88% | ||
| Current year | +5.19% |
| 1 week | 6.45 | 6.65 | |
| 1 month | 5.97 | 7.85 | |
| Current year | 5.15 | 12 | |
| 1 year | 3.85 | 12 | |
| 3 years | 2.22 | 17.7 | |
| 5 years | 2.22 | 50.25 | |
| 10 years | 2.22 | 990 |
| Manager | Title | Age | Since |
|---|---|---|---|
Thomas Burnell
CEO | Chief Executive Officer | 64 | 30/11/2020 |
| Director of Finance/CFO | 34 | 20/04/2023 | |
Nicole Massoll
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Sullivan
CHM | Chairman | 79 | 20/06/2016 |
Joseph Keegan
BRD | Director/Board Member | 73 | 31/12/2015 |
Fortunato Rocca
BRD | Director/Board Member | 64 | 21/01/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 20/08/26 | Free | Director | 69,252 | 0.2501% | ||
| 20/08/26 | Exercice | Chief Financial Officer | 1,385,045 | 5.0015% | ||
| 20/08/26 | Free | Director | 69,252 | 0.2501% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.31% | -0.46% | +57.75% | +12.52% | 35.84M | ||
| +5.47% | +11.44% | +118.15% | +753.12% | 56.35B | ||
| -2.94% | -3.84% | +11.70% | +51.86% | 25.27B | ||
| -0.63% | -2.71% | -13.90% | -37.94% | 6.72B | ||
| +1.73% | -4.14% | -2.26% | +167.77% | 5.82B | ||
| -0.70% | -0.03% | +13.82% | +58.86% | 3.34B | ||
| -7.19% | -4.06% | -30.04% | +2,429.25% | 2.71B | ||
| -2.68% | 0.00% | +124.88% | +55.47% | 2.43B | ||
| +0.59% | +3.90% | +38.71% | +48.59% | 2.35B | ||
| +1.04% | +8.03% | -4.03% | -53.41% | 1.98B | ||
| Average | -0.51% | +0.89% | +31.48% | +348.61% | 10.7B | |
| Weighted average by Cap. | +2.01% | +4.94% | +67.29% | +480.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 46.93M 41.01M 38.54M 35.17M 66.01M 4.49B 66.02M 463M 178M 2.29B 176M 172M 7.39B | 38.73M 33.84M 31.81M 29.03M 54.48M 3.7B 54.49M 382M 147M 1.89B 145M 142M 6.1B |
| Net income | 6.7M 5.86M 5.5M 5.02M 9.43M 641M 9.43M 66.07M 25.49M 327M 25.17M 24.62M 1.05B | 24.58M 21.48M 20.18M 18.42M 34.57M 2.35B 34.58M 242M 93.48M 1.2B 92.29M 90.27M 3.87B |
| Net Debt | 4.4M 3.84M 3.61M 3.29M 6.18M 420M 6.18M 43.32M 16.72M 215M 16.5M 16.14M 692M | -1.32M -1.16M -1.09M -991K -1.86M -126M -1.86M -13.03M -5.03M -64.54M -4.96M -4.86M -208M |
Employees
102
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/09/26 | US$6.470 | +0.31% | 1,489 |
| 18/09/26 | US$6.450 | 0.00% | 723 |
| 17/09/26 | US$6.450 | 0.00% | 170 |
| 16/09/26 | US$6.450 | -0.77% | 512 |
| 15/09/26 | US$6.500 | +3.17% | 676 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- IDXGD Stock
Select your edition
All financial news and data tailored to specific country editions

















